Molecular Endocrinology and Metabolism
A section of International Journal of Molecular Sciences (ISSN 1422-0067).
Section Information
This section of the International Journal of Molecular Sciences (IJMS) aims to rapidly publish original contributions and reviews on all aspects of endocrinology and metabolism. We encourage the submission of manuscripts that report significant advances in those fields. Topics include, but are not limited to, the following:
- Endocrine systems and endocrine-related diseases;
- Molecular, cellular, genetic, epigenetic, developmental approaches, and animal models;
- Novel insights into physiology, pathophysiology, and therapeutics;
- Neuroendocrinology and neuroendocrine control of endocrine axes;
- Classical glands (thyroid, adrenal, pituitary, parathyroid, testis, ovary, pituitary, etc.) and other endocrine systems: gut, bone, liver, etc.;
- Lipids and bone metabolism;
- Hormones, paracrine factors, receptors and binding components, nuclear receptors membrane receptors, signal transduction pathway;
- Steroid biosynthetic enzymes, metabolism of hormones, neurotransmitters, etc.;
- Cellular interactions and factors involved;
- Energy expenditure;
- Diabetes;
- Infertility and reproductive diseases;
- Obesity;
- Osteoporosis;
- Aging;
- Endocrine-related tumor and cancer;
- Endocrine disruption;
- Crossdisciplinary and integrative studies;
- Comparative aspects of endocrinology.
Editorial Board
Topic Board
Special Issues
Following special issues within this section are currently open for submissions:
- Cell Therapy for Stress Urinary Incontinence and Other Age-Related Diseases (Deadline: 30 April 2021)
- Bone Ontogeny, Embryology, and Homeostasis (Deadline: 30 April 2021)
- Cancer Cell Metabolism (Deadline: 30 April 2021)
- Novel Biomarkers in Cardiovascular Disease: From Bench to Bedside (Deadline: 30 April 2021)
- Molecular Mechanisms of the Pro-healthy Effects of Exercise (Deadline: 30 April 2021)
- Glycomics: Implications for Metabolic Health and Disease (Deadline: 30 April 2021)
- Nonapeptide Hormones (Deadline: 30 April 2021)
- Metabolic Therapies for Heart Failure (Deadline: 30 April 2021)
- Micronutrients in Metabolic Health (Deadline: 30 April 2021)
- Regulation of Bone Mineral Homeostasis (Deadline: 30 April 2021)
- Oxytocin: Involvement in Metabolic Disorders (Deadline: 30 April 2021)
- Osteoporosis (Deadline: 15 May 2021)
- Targeting Mitochondria in Metabolic Diseases (Deadline: 31 May 2021)
- Extracellular Vesicles as a New Source of Liquid Biopsy 2.0 (Deadline: 31 May 2021)
- Molecular Mechanisms of Diabetes-Associated Kidney Disease (Deadline: 31 May 2021)
- Steroids, Central Neurotransmission, Mood, Memory and Mental State (Deadline: 31 May 2021)
- Signaling Pathways in Inflammation and Its Resolution: New Insights and Therapeutic Challenges (Deadline: 1 June 2021)
- Peripheral Artery Disease: From Molecular Mechanisms to Therapeutic Approaches (Deadline: 30 June 2021)
- Molecular Mechanism(s) of Non-steroidal Anti-inflammatory Drugs in the Prevention of Metabolic Diseases (Deadline: 30 June 2021)
- Gonadotropin-Releasing Hormone Receptor Signaling and Functions 2.0 (Deadline: 30 June 2021)
- Receptors, Transmitters, and Signaling Pathways in Thyroid Disorders and Diabetes 2.0 (Deadline: 30 June 2021)
- Function and Mechanism of Regulatory Non-Coding RNAs in Obesity and Related Diseases (Deadline: 30 June 2021)
- Cancer Metabolism: From Cancer Cell to Cancer Cachexia (Deadline: 30 June 2021)
- Steroids and Lipophilic Hormones, and Their Actions 2.0 (Deadline: 30 June 2021)
- Nonalcoholic Fatty Liver Disease/Metabolic Associated Fatty Liver Disease: New Insights (Deadline: 30 June 2021)
- New Aspects of Steroid Hormone Action in Hormone Dependent Diseases (Deadline: 30 June 2021)
- Role of Insulin Clearance in Insulin Action and Metabolic Diseases (Deadline: 30 June 2021)
- Endocannabinoid System in Health and Disease: Current Situation and Future Perspectives 3.0 (Deadline: 30 June 2021)
- Enzymes and Mammalian Fatty Acid Metabolism (Deadline: 30 June 2021)
- Molecular Metabolic Regulation in Diabetes 2.0 (Deadline: 30 June 2021)
- Adipokines in Health and Diseases (Deadline: 30 June 2021)
- Role of Interleukin Genes in Etiopathogenesis of Multifactorial Traits and Diseases (Deadline: 30 June 2021)
- Mitochondrial Protein Network: From Biogenesis to Bioenergetics in Health and Disease 2.0 (Deadline: 30 June 2021)
- Neuropeptides in Food Intake Regulation (Deadline: 30 June 2021)
- Phosphate-Related Disorders: From Physiology to Diseases (Deadline: 15 July 2021)
- Microenvironment in Cancer Progression and Metastases 2.0 (Deadline: 20 July 2021)
- Molecular Pathways for Vascular Risk in Diabetes (Deadline: 31 July 2021)
- Metformin: The Scope for New Applications (Deadline: 31 July 2021)
- Candidate Biomarkers in Pathophysiology and Diagnostics of Endocrinopathies (Deadline: 31 July 2021)
- Endothelial Cell Senescence in Ageing and Disease (Deadline: 31 July 2021)
- Molecular Studies on Hypogonadism and Prader–Willi Syndrome (Deadline: 31 July 2021)
- Biomarkers in Rare Diseases 2.0 (Deadline: 31 July 2021)
- The Renin Angiotensin System, Molecular, Geroscience and Aging-Related Disorders 2.0 (Deadline: 31 July 2021)
- Biased Agonism in GPCRs: An Opportunity for Drug Discovery (Deadline: 31 July 2021)
- Regenerative Medicine for the Musculoskeletal System (Deadline: 31 July 2021)
- Therapeutic Modulation of Mesenchymal Stem Cells for Effective Regenerative Medicine 2.0 (Deadline: 31 July 2021)
- Molecular Pathophysiology of Testosterone Biosynthesis (Deadline: 31 July 2021)
- Early Life Nutrition and the Development of Offspring Metabolic Health (Deadline: 31 July 2021)
- Allosteric Modulators of GPCRs (Deadline: 31 July 2021)
- Type 2 Diabetes and Cardiovascular Disease: Pathophysiological Mechanisms and Effects of SGLT-2i and GLP-1RAs (Deadline: 31 July 2021)
- Central and Local Modulators of Reproduction and Fertility: An Update (Deadline: 31 July 2021)
- The Role of Estrogen Receptors in Health and Disease 2.0 (Deadline: 31 July 2021)
- Obesity, Genes, and Obesity-Related Disorders (Deadline: 31 July 2021)
- From Ageing and Vascular Ageing to Specific Treatment of Age-Related Disorders (Deadline: 31 July 2021)
- Preventive and Therapeutic Strategies in Vascular Dysfunction (Deadline: 31 July 2021)
- Mechanisms of Cardiovascular Disease: Molecular Perspective (Deadline: 31 July 2021)
- Hormones and Receptors in Sexual Reproduction (Deadline: 2 August 2021)
- The Role of Interleukin in Health and Diseases (Deadline: 15 August 2021)
- The Role of Vitamin D in Human Health and Diseases (Deadline: 15 August 2021)
- Molecular and Cellular Advances in Endometriosis Research (Deadline: 15 August 2021)
- Molecular Background of Male and Female Central Hypogonadism 2.0 (Deadline: 30 August 2021)
- Flow Cytometry (Deadline: 30 August 2021)
- The Role of PARPs in Cancer and Aging (Deadline: 31 August 2021)
- Molecular, Proteomic and Metabolic Markers for Early Detection of Cancer (Deadline: 31 August 2021)
- Colorectal Cancer and Adjacent Normal Mucosa Differ in Apoptotic and Inflammatory Protein Expression (Deadline: 31 August 2021)
- Molecular Basis of Fertility Preservation and Restoration 3.0 (Deadline: 31 August 2021)
- Energy Metabolism in Health and Disease (Deadline: 31 August 2021)
- Molecular Mechanism Underlying the Endocrine Abnormalities Associated with Severe Illness (Deadline: 31 August 2021)
- Coping with Environmental Stress Oscillations: An Integrative Approach (Deadline: 31 August 2021)
- Lipids and Brain Aging (Deadline: 31 August 2021)
- Molecular Metabolisms in Cartilage Health and Diseases (Deadline: 31 August 2021)
- Diet and Metabolism: Molecular Mechanisms of Health and Disease (Deadline: 31 August 2021)
- Molecular Biology of the Pituitary 2.0 (Deadline: 31 August 2021)
- Impact of Diet on Cancer Therapy (Deadline: 31 August 2021)
- Therapeutic Effects of Plant Based Bioactive Compounds on Cancer (Deadline: 31 August 2021)
- Metabolic and Vascular Effects of Mediterranean Diet 2.0 (Deadline: 31 August 2021)
- Molecular and Hormonal Advances in Amenorrhea (Deadline: 31 August 2021)
- Novel Insights on the Molecular Aspects of Endocrine Disorders in Childhood (Deadline: 31 August 2021)
- Puberty and Its Disorders: From Neuro-Regulation of Puberty Onset to Molecular Basis and Management of Pubertal Disorders (Deadline: 31 August 2021)
- Development, Differentiation, and Toxicity in Reproduction (Deadline: 31 August 2021)
- Protein Kinases in Metabolic Disorders (Deadline: 31 August 2021)
- Metabolic Bone Diseases: Molecular Biology, Pathophysiology and Therapy 2.0 (Deadline: 31 August 2021)
- B-Cell Malignancies (Deadline: 31 August 2021)
- Sexual Dimorphism in (Non Reproductive) Endocrine Diseases (Deadline: 31 August 2021)
- Extracellular Vesicles in Endocrine and Endocrine-Dependent Cancer 2.0 (Deadline: 31 August 2021)
- Protein Kinases and Phosphatases in Neurodevelopmental Disorders (Deadline: 31 August 2021)
- Impact of Endogenic and Exogenic Oxidative Stress Triggers on Pregnant Woman, Fetus, and Child (Deadline: 1 September 2021)
- Secondary Osteoporosis in Adults 2.0 (Deadline: 10 September 2021)
- Advances in Kinase Drug Discovery 2.0 (Deadline: 30 September 2021)
- Iron and Folate in Women’s Health (Deadline: 30 September 2021)
- Platelet Activation and Prothrombotic Factors for Atherosclerosis (Deadline: 30 September 2021)
- New Research on Endocrine Regulation of Brain Development (Deadline: 30 September 2021)
- Health Benefits of Resveratrol 3.0 (Deadline: 30 September 2021)
- Molecular Pathology, Diagnostics, and Therapeutics of Adrenal Incidentalomas (Deadline: 30 September 2021)
- Conserved Pathways in Development and Cancer (Deadline: 30 September 2021)
- Molecular Biology of Parathyroid Tumors 2.0 (Deadline: 30 September 2021)
- Molecular pathophysiology, Genetic Diagnosis and Therapeutic Strategies for Lipodystrophies (Deadline: 30 September 2021)
- Calcium Handling (Deadline: 30 September 2021)
- Molecular Mechanisms at the Basis of Systemic Complications of Glycogen Metabolism Disorder (Deadline: 30 September 2021)
- Disorders of Mitochondrial Metabolism (Deadline: 30 September 2021)
- Mechanisms of Endocrine and Molecular Bone Regulation (Deadline: 30 September 2021)
- The Role of Tissue-Nonspecific Alkaline Phosphatase in Inflammation and Metabolic Syndrome 2.0 (Deadline: 30 September 2021)
- New advance in Rare Monoclonal Gammapathies (Deadline: 30 September 2021)
- Molecular Research in Allergic Diseases 2.0 (Deadline: 30 September 2021)
- Central and Peripheral Molecular Mechanisms of Metabolism Regulation 2.0 (Deadline: 30 September 2021)
- Molecular Mechanisms of Muscle Fatigue (Deadline: 15 October 2021)
- Role of Dysfunctional Adipose Tissue in the Pathogenesis of Multiple Organ Injuries (Deadline: 30 October 2021)
- MicroRNA, Insulin Resistance, and Metabolic Disorders (Deadline: 31 October 2021)
- Cardiometabolic Risk: From Omic Technologies to Therapeutic Perspective (Deadline: 31 October 2021)
- Congenital Disorders of Glycosylation (CDG): Molecular Mechanism and Therapeutic Approaches (Deadline: 31 October 2021)
- Non-Classical Steroid Hormone Regulatory Mechanism (Deadline: 31 October 2021)
- Feature Papers in Molecular Endocrinology and Metabolism (Deadline: 31 October 2021)
- New Advance in Diabetes Genetics (Deadline: 31 October 2021)
- Neuroprotection: Rescue from Neuronal Death in the Brain 2.0 (Deadline: 31 October 2021)
- Human Saliva as a Source of Biomarkers for Oral Diseases (Deadline: 31 October 2021)
- Innovation in Ovulation Triggering and Luteal Phase Support to Improve Embryo Implantation (Deadline: 30 November 2021)
- Novel Drugs for Infertility Treatment: From Molecular Structure to Patient Value (Deadline: 30 November 2021)
- Drosophila as a Model of Cardiac Diseases and Heart Aging (Deadline: 30 November 2021)